Molecular profiling predicts the existence of two functionally distinct classes of ovarian cancer stroma

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Lili, Loukia N ^a   Matyunina, Lilya V ^a   Walker, L Deette ^a   Benigno, Benedict B ^b   McDonald, John F ^a,b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b Ovarian Cancer Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; CXCL13 CHEMOKINE; CXCL16 CHEMOKINE; CXCL3 CHEMOKINE; CXCL9 CHEMOKINE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 9; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 27; INTERLEUKIN 7; KERATINOCYTE GROWTH FACTOR; STROMAL CELL DERIVED FACTOR 1; CELL SURFACE RECEPTOR; LIGAND;

ARTICLE; CANCER GROWTH; CANCER PATIENT; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; MICROARRAY ANALYSIS; OVARY ADENOCARCINOMA; OVARY CANCER; PREDICTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STROMA CELL; TISSUE MICROARRAY; ADULT; AGED; CLUSTER ANALYSIS; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; OVARY; OVARY TUMOR; PATHOLOGY;

ADULT; AGED; CLUSTER ANALYSIS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIGANDS; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY; RECEPTORS, CELL SURFACE; STROMAL CELLS;

EID: 84878723682     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/846387     Document Type: Article

References (30)

1. Liotta L. A., Kohn E. C., The microenvironment of the tumour-host interface. Nature 2001 411 6835 375 379 2-s2.0-0035902141 10.1038/35077241 (Pubitemid 32467047)
2. Bhowmick N. A., Moses H. L., Tumor-stroma interactions. Current Opinion in Genetics and Development 2005 15 1 97 101 2-s2.0-12344328353 10.1016/j.gde.2004.12.003 (Pubitemid 40127637)
3. Tlsty T. D., Coussens L. M., Tumor stroma and regulation of cancer development. Annual Review of Pathology 2006 1 119 150 2-s2.0-33645739790 10.1146/annurev.pathol.1.110304.100224
4. Hanahan D., Weinberg R. A., The hallmarks of cancer. Cell 2000 100 1 57 70 2-s2.0-0034614637 (Pubitemid 30046295)
5. Kamat A. A., Fletcher M., Gruman L. M., Mueller P., Lopez A., Landen C. N. Jr., Han L., Gershenson D. M., Sood A. K., The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer. Clinical Cancer Research 2006 12 6 1707 1714 2-s2.0-33645676359 10.1158/1078-0432.CCR-05-2338
6. Zhang L., Yang N., Park J. W., Katsaros D., Fracchioli S., Cao G., O'Brien-Jenkins A., Randall T. C., Rubin S. C., Coukos G., Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Research 2003 63 12 3403 3412 2-s2.0-0038745370 (Pubitemid 36735901)
7. Porcile C., Bajetto A., Barbieri F., Barbero S., Bonavia R., Biglieri M., Pirani P., Florio T., Schettini G., Stromal cell-derived factor-1 α (SDF-1 α /CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation. Experimental Cell Research 2005 308 2 241 253 2-s2.0-24944553762 10.1016/j.yexcr.2005.04.024
8. Wang E., Ngalame Y., Panelli M. C., Nguyen-Jackson H., Deavers M., Mueller P., Hu W., Savary C. A., Kobayashi R., Freedman R. S., Marincola F. M., Peritoneal and subperitoneal stroma may facilitate regional spread of ovarian cancer. Clinical Cancer Research 2005 11 1 113 122 2-s2.0-19944426988 (Pubitemid 40075785)
9. Micke P., Östman A., Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? Lung Cancer 2004 45 supplement 2 S163 S175 2-s2.0-8444250723 10.1016/j.lungcan.2004.07.977 (Pubitemid 39488186)
10. Silva A., Gírio A., Cebola I., Santos C. I., Antunes F., Barata J. T., Intracellular reactive oxygen species are essential for PI3K/Akt/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells. Leukemia 2011 25 6 960 967 2-s2.0-79958125269 10.1038/leu.2011.56
11. Schroten C., Dits N. F., Steyerberg E. W., Kranse R., van Leenders A. G., Bangma C. H., Kraaij R., The additional value of TGF β 1 and IL-7 to predict the course of prostate cancer progression. Cancer Immunology, Immunotherapy 2012 61 6 905 910 10.1007/s00262-011-1159-3
12. Al-Rawi M. A. A., Mansel R. E., Jiang W. G., Interleukin-7 (IL-7) receptor (IL-7R) signalling complex in human solid tumours. Histology and Histopathology 2003 18 3 911 923 2-s2.0-0037789421 (Pubitemid 36773235)
13. Maeurer M. J., Walter W., Martin D., Zitvogel L., Elder E., Storkus W., Lotze M. T., Interleukin-7 (IL-7) in colorectal cancer: IL-7 is produced by tissues from colorectal cancer and promotes preferential expansion of tumour infiltrating lymphocytes. Scandinavian Journal of Immunology 1997 45 2 182 192 2-s2.0-0001304588 (Pubitemid 27047248)
14. Bhowmick N. A., Neilson E. G., Moses H. L., Stromal fibroblasts in cancer initiation and progression. Nature 2004 432 7015 332 337 2-s2.0-9244227134 10.1038/nature03096 (Pubitemid 39551661)
15. Jin C., Wang F., Wu X., Yu C., Luo Y., McKeehan W. L., Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors. Cancer Research 2004 64 13 4555 4562 2-s2.0-3042826804 10.1158/0008-5472.CAN-03-3752 (Pubitemid 38856928)
16. Turner N., Grose R., Fibroblast growth factor signalling: from development to cancer. Nature Reviews Cancer 2010 10 2 116 129 2-s2.0-75149170979 10.1038/nrc2780
17. Reya T., Clevers H., Wnt signalling in stem cells and cancer. Nature 2005 434 7035 843 850 2-s2.0-17244376814 10.1038/nature03319 (Pubitemid 40558990)
18. Bui T. D., Lako M., Lejeune S., Curtis A. R. J., Strachan T., Lindsay S., Harris A. L., Isolation of a full-length human WNT7A gene implicated in limb development and cell transformation, and mapping to chromosome 3p25. Gene 1997 189 1 25 29 2-s2.0-0030994848 10.1016/S0378-1119(96)00808-6 (Pubitemid 27183168)
19. Yoshioka S., King M. L., Ran S., Okuda H., MacLean J. A. II, McAsey M. E., Sugino N., Brard L., Watabe K., Hayashi K., WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/ β -catenin pathway. Molecular Cancer Research 2012 10 3 469 482 10.1158/1541-7786.MCR-11-0177
20. Tchagang A. B., Tewfik A. H., DeRycke M. S., Skubitz K. M., Skubitz A. P. N., Early detection of ovarian cancer using group biomarkers. Molecular Cancer Therapeutics 2008 7 1 27 37 2-s2.0-38349135710 10.1158/1535-7163.MCT-07-0565
21. Ricken A., Lochhead P., Kontogiannea M., Farookhi R., Wnt signaling in the ovary: identification and compartmentalized expression of wnt-2, wnt-2b, and frizzled-4 mRNAs. Endocrinology 2002 143 7 2741 2749 2-s2.0-0036290365 10.1210/en.143.7.2741 (Pubitemid 34701338)
22. Hanahan D., Weinberg R. A., Hallmarks of cancer: the next generation. Cell 2011 144 5 646 674 2-s2.0-79952284127 10.1016/j.cell.2011.02.013
23. Nowicki A., Szenajch J., Ostrowska G., Wojtowicz A., Wojtowicz K., Kruszewski A. A., Maruszynski M., Aukerman S. L., Wiktor-Jedrzejczak W., Impaired tumor growth in colony-stimulating factor 1 (CSF-1)-deficient, macrophage-deficient op/op mouse: evidence for a role of CSF-1-dependent macrophages in formation of tumor stroma. International Journal of Cancer 1996 65 1 112 119 (Pubitemid 26030942)
24. Pawelec G., Tumour escape: antitumour effectors too much of a good thing? Cancer Immunology, Immunotherapy 2004 53 3 262 274 2-s2.0-1542357603 10.1007/s00262-003-0469-5 (Pubitemid 38328050)
25. Yang L., Carbone D. P., Tumor-host immune interactions and dendritic cell dysfunction. Advances in Cancer Research 2004 92 13 27 2-s2.0-7644237187 10.1016/S0065-230X(04)92002-7 (Pubitemid 39458111)
26. Coussens L. M., Werb Z., Inflammation and cancer. Nature 2002 420 6917 860 867 2-s2.0-0037180757 10.1038/nature01322 (Pubitemid 36019639)
27. Kalluri R., Zeisberg M., Fibroblasts in cancer. Nature Reviews Cancer 2006 6 5 392 401 2-s2.0-33646384428 10.1038/nrc1877
28. Gillessen S., Naumov Y. N., Nieuwenhuis E. E. S., Exley M. A., Lee F. S., Mach N., Luster A. D., Blumberg R. S., Taniguchi M., Balk S. P., Strominger J. L., Dranoff G., Wilson S. B., CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion. Proceedings of the National Academy of Sciences of the United States of America 2003 100 15 8874 8879 2-s2.0-0042808528 10.1073/pnas.1033098100 (Pubitemid 36899191)
29. Gonda T. A., Varro A., Wang T. C., Tycko B., Molecular biology of cancer-associated fibroblasts: can these cells be targeted in anti-cancer therapy? Seminars in Cell and Developmental Biology 2010 21 1 2 10 2-s2.0-75849116069 10.1016/j.semcdb.2009.10.001
30. Parrott J. A., Nilsson E., Mosher R., Magrane G., Albertson D., Pinkel D., Gray J. W., Skinner M. K., Stromal-epithelial interactions in the progression of ovarian cancer: influence and source of tumor stromal cells. Molecular and Cellular Endocrinology 2001 175 1-2 29 39 2-s2.0-0035946581 10.1016/S0303-7207(01)00436-1 (Pubitemid 32372541)